Providing veterinarians access to more safe and effective animal drugs is central to the recently reauthorized Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA).
Endorsed by the American Veterinary Medical Association (AVMA), the legislation that was included and passed by the Congress, is up for reauthorization every five years. This utilizes the collection of user fees to enhance the U.S. Food and Drug Administration Center for Veterinary Medicine’s (FDA CVM) review of pioneer and generic animal drugs.
“Building a robust pipeline of innovative new animal drugs and ensuring a strong generic industry is vital to veterinary medicine,” says Lori Teller, DVM, DABVP (Canine/Feline), CVJ, AVMA immediate past president. “As a result of the legislation, we will have access to more safe and effective animal drugs to treat the animals under our care. It was an honor to testify before Congress on this important issue and it highlights how critical it is for veterinarians to be part of the discussion during the legislative process. The AVMA is grateful to lawmakers for recognizing how these user fee programs support animal welfare by increasing the number of affordable, safe, and effective treatment options readily available to veterinarians.”
For more information, click here.